A clinical trial to evaluate the effect of OTL-200, a gene therapy treatment in patients with Late Juvenile (LJ) Metachromatic Leukodystrophy (MLD) A clinical trial to evaluate the effect of OTL-200, a gene therapy treatment in patients with Late J ...
An open label, non-randomised trial to evaluate the safety and efficacy of a single infusion of OTL-200 in patients with Late Juvenile (LJ) Metachromatic Leukodystrophy (MLD) An open label, non-randomised trial to evaluate the safety and efficacy of a single infusion of OTL- ...
Product Code: OTL-200 INN or Proposed INN: Not Applicable Other descriptive name: OTL-200 Dispersion for InfusionProduct Code: OTL-200 INN or Proposed INN: Not Applicable Other descriptive name: OTL-200 Dispersion f ...
Gene therapy study using a frozen formulation of OTL-200 in patients with Metachromatic Leukodystrophy (MLD). Gene therapy study using a frozen formulation of OTL-200 in patients with Metachromatic Leukodystrop ...
A single arm, open label, clinical study of cryopreserved autologous CD34+ cells transduced with lentiviral vector containing human ARSA cDNA OTL-200, for the treatment of early onset Metachromatic Leukodystrophy (MLD). - A clinical study using cryopreserved OTL-200 for treatment of MLD. A single arm, open label, clinical study of cryopreserved autologous CD34+ cells transduced with len ...